The new strategy called Receptorchem represents a exciting route for focused therapeutic delivery. It depends on engineering agents that selectively bind to antigens expressed on cancerous structures. Beyond standard https://bookmarkssocial.com/story22048580/receptorchem-a-novel-approach-to-targeted-drug-delivery